CONTACT:
Jud Hall
877.443.4006
Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is proud to announce the latest opening of an Advanced Infusion Care Center (AICC). This new location in Atlanta, GA is the latest example of AIC’s ongoing growth and commitment to helping people access compassionate, high-quality infusion services across the country.
Establishing additional infusion centers sites reinforces AIC’s strategic dedication to addressing the growing need for outpatient infusion therapy. Each infusion center is designed based on a modern, patient-focused approach, and emphasizes comfort, convenience, and clinical excellence. The Atlanta location is now accepting referrals, and is open and ready to deliver reliable, individualized infusion therapy to patients in the region.
“Opening our Atlanta infusion center is an important milestone” said Simon Castellanos, CEO of AIS Healthcare. “We are thrilled to broaden our footprint in Georgia and provide patients with more convenient options for receiving the compassionate, high-quality care they deserve right in their own community.”
All infusion center locations offer a wide range of therapies for both long-term and short-term conditions and ensure that patients have access to the newest FDA-approved treatments. In addition, each center is built to support diverse clinical needs, with specialties in neurology, gastroenterology, rheumatology, dermatology, immunology, pulmonology, ophthalmology, and endocrinology. Each center also offers private treatment rooms for added comfort, flexible scheduling options, and highly skilled clinical staff.
“At AIC, we understand that infusion therapy is more than a procedure—it’s an essential part of a patient’s overall health and quality of life,” said Jud Hall, President of AIC. “Our approach is centered on reducing wait times and increasing meaningful care. With private rooms, adaptable appointment options, and highly trained medical professionals, we ensure that every patient receives care designed around their needs.”
AIC is a full-service partner to clinicians and works collaboratively with their offices as well as insurance companies and patients to secure all required authorizations and approvals and has dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC)—further evidencing AIC’s place as a trusted leader in infusion care.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
CONTACT:
Jud Hall
877.443.4006
Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country.
The opening of more and more AICC sites highlights AIC’s strategic dedication to addressing the rising demand for outpatient infusion therapy. Designed based on a modern, patient-focused approach, the Centers emphasize comfort, convenience, and clinical excellence. Now accepting referrals, the Marietta location is ready to deliver individualized infusion therapy to the patients who depend on these services in the greater Atlanta region.
“We are truly excited to open our new infusion Center in Marietta, GA as it represents another meaningful step in our mission to bring high-quality, personalized care closer to the patients who need it most,” said Simon Castellanos, CEO of AIS Healthcare. “This expansion allows us to better support the community while continuing to raise the standard for outpatient infusion services nationwide.”
Offering a wide range of therapies for both long-term and short-term conditions, AICC—including the Marietta location—ensure that patients have access to the newest FDA-approved treatments. The Centers are built to support diverse clinical needs, with specialties in neurology, gastroenterology, rheumatology, dermatology, immunology, pulmonology, ophthalmology, and endocrinology. In Marietta, patients will find private treatment rooms for added comfort, flexible scheduling options, and highly skilled clinical staff.
“At AIC, we understand that infusion therapy is more than a procedure—it’s an essential part of a patient’s overall health and quality of life,” said Jud Hall, President of AIC. “Our approach is centered on reducing wait times and increasing meaningful care. With private rooms, adaptable appointment options, and highly trained medical professionals, we ensure that every patient receives care designed around their needs.”
As a full-service partner to clinicians, AIC works collaboratively with provider offices, insurance companies, and patients to secure all required authorizations and approvals. Dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC) further sets AIC apart as a trusted leader in infusion care.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
CONTACT:
Jud Hall
877.443.4006
Dallas, TX- AIC, a division of AIS Healthcare, now offers YIMMUGO®, manufactured by Kedrion Biopharma, for the treatment of primary humoral immunodeficiency in patients 2 years of age and older.
Approved by the U.S Food and Drug Administration in June 2024, YIMMUGO® is now available at all AIC locations.
The nationally accredited infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or in an infusion center setting. This new immunoglobulin (Ig) therapeutic option continues to expand AIC’s ability to better serve patients with primary immunodeficiency (PI).
“We are thrilled to add YIMMUGO® to our extensive and comprehensive list of Ig infusion therapies,” said Jud Hall, President of AIC. “AIC is proud to partner with Kedrion Biopharma as a specialty pharmacy limited distribution network member to offer exclusive access to this highly purified IVIg treatment option to patients nationwide”, added Stan Singley, AIC’s Vice President of Trade & Procurement.”
Like all AIC patients, those with PI will receive a high level of care from AIC, including 24/7 access to clinical and support staff. Every patient is assigned a dedicated team of professionals, including clinical pharmacists, infusion nurses, RN clinical review specialists, and patient access specialists to provide support throughout the treatment process.
For physicians, AIC is more than a specialty pharmacy. We are a full-service care delivery partner, and we have contracts with multiple immunoglobulin suppliers, like Kedrion Biopharma. These contracts help us ensure prescribed therapies are always in stock. We also work directly with patients, insurance companies, and physician offices to secure all needed insurance authorizations and approvals.
AIS Healthcare, and the AIC Division, are dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/
Advancing quality. Improving lives.
As the leading provider of infusion care solutions and targeted drug delivery, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
Kedrion Biopharma collects and fractionates blood plasma to produce and distribute plasma-derived therapies for rare, ultra-rare, and debilitating conditions like Coagulation and Neurological Disorders, Immunodeficiencies, and Rh sensitization. We employ approximately 5,200 people worldwide and our industrial network includes 68 plasma collection centers in the United States and 8 in the Czech Republic, and 7 production facilities across 5 countries. We are committed to creating a world where science and care know no bounds, partnering with the medical-scientific community, institutions, patient advocacy groups, and research bodies to foster innovation and improve care. Every connection we make impacts someone, somewhere.
Learn more at kedrion.com.
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas—AIS Healthcare has been awarded a group purchasing agreement for 503A intrathecal compounded medications with Premier, Inc., effective July 1, 2025. The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for sterile, patient-specific intrathecal pain pump medications.
In addition, to assist with compliance policies, this agreement with Premier will provide member hospitals with site audit evaluations as well as ongoing quality reporting.
“Partnering with Premier allows us to bring our highquality, patientspecific medications and services to more patients and providers across the country. By combining Premier’s expansive network with our expertise in delivering safe, reliable, and longerdated compounded medications, we can help meet the growing 503A outsourcing needs for Premier’s member organizations with confidence and consistency. Together, we are delivering the best possible care to patients,” said Simon Castellanos, CEO of AIS Healthcare.
Premier, Inc. is a leading healthcare improvement company, bringing more than 4,400 US hospitals and health systems and approximately 250,000 other providers and organizations together to transform health care. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.
AIS Healthcare is a 503A pharmacy that compounds intrathecal medications for Targeted Drug Delivery (TDD). As the leading provider of TDD, AIS Healthcare is committed to providing industry leading intrathecal medications and the highest quality care.
At the center of our TDD operation are our 2 state-of-the-art 503A specialty compounding pharmacies, which prepare and ship more than 145,000 patient-specific prescriptions annually.
At both facilities, we go beyond industry and state standards to produce medications of the highest quality. We use a proven, proprietary process that combines aseptic processing with terminal sterilization on patient-specific prescriptions to achieve higher sterility assurance and extended Beyond-Use Dates (BUD).
To learn more about AIS Healthcare, please contact Chad Jeske at cjeske@aiscaregroup.com or visit our website at https://www.aiscaregroup.com.
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it has been named a 2024 Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program. This is the second year in a row that AIS Healthcare has been recognized as a Pioneer by URAC for promoting trust in the quality of care delivered through performance measurement activities.
To be recognized with the Pioneer in Performance Measurement Award, an organization is required to make key contributions to advance performance measurements and participate in activities that go beyond the mandatory reporting requirements, such as submission of exploratory measures, all with the purpose of helping improve the health and well-being of the populations being served.
URAC is one of the nation’s leading independent health care accreditation organizations, with certification programs that set the highest standards in quality and safety.
“We are honored to have been named a 2024 Pioneer by URAC,” said Simon Castellanos, AIS Healthcare CEO. “This recognition, for the second year in a row, is a testament to the dedication of our entire company to put patient safety first. I could not be prouder of this team and their unwavering commitment to ensuring quality, sterility, and excellence across all our pharmacy operations.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients.
AIS Healthcare is also dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers.
Learn more at aiscaregroup.com
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
About URAC
Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare. Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – In response to recent hurricanes that devastated many communities across the Southeastern United States, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is providing additional support to physicians and patients to ensure continuity of care and access to life-saving medication. The destruction of critical infrastructure and extended power outages have created acute challenges for patients who rely on timely delivery and sustained access to medication used to treat severe chronic pain and spasticity.
To address these near-term supply chain disruptions, AIS Healthcare is increasing capacity at its pharmacies in Texas and Mississippi, which were not impacted by the hurricanes. This additional production capacity is intended to meet the demand of physicians and patients who use other pharmacies and may be struggling to access their medication.
“Our thoughts are with all the communities in the Southeast that have experienced immense tragedy and destruction over the last several weeks,” said Simon Castellanos, CEO of AIS Healthcare. “We see it as our responsibility to support physicians and patients in the one area we can – ensuring continuity of care by making essential medications available. Our pharmacy teams have been working around the clock to add capacity and respond to physicians and patients who cannot wait to have their next prescription filled. I’m proud of the work we have done and believe it is absolutely crucial we take action to provide essential medication in times of crises. We are committed to doing whatever is necessary to help all physicians, patients, and our industry during this difficult time.”
AIS Healthcare is dedicated to prioritizing the health and safety of all patients in need of care during this period of recovery. To support those who are recovering from hurricanes Milton and Helene, the American Red Cross is accepting donations here.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
CONTACT:
Jud Hall
877.443.4006
Dallas, TX- AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID).
The nationally accredited home infusion teams at AIC collaborate closely with physicians to provide specialized infusion services to patients in their home or in an infusion suite setting. This new immunoglobulin (Ig) therapeutic option will expand AIC’s ability to better serve PI patients.
“We are excited to add ALYGLO™ to our expansive list of Ig infusion therapies,” said Jud Hall, President of AIC. “AIC is proud to partner with GC Biopharma to offer this extra-purified IVIg replacement therapy as another treatment option to patients nationwide”, added Stan Singley, Vice President of Trade & Procurement.”
Approved by the U.S Food and Drug Administration in 2023, ALYGLO™ is now available at all AIC locations (Valdosta, GA; Birmingham, AL; Panama City, FL; Cockeysville, MD; and Dallas, TX).
Like all AIC patients, those with PI will receive a high level of care from AIC, including 24/7 access to clinical and support staff. Every patient is assigned a dedicated team of professionals, including clinical pharmacists, home infusion nurses, RN clinical review specialists, and patient access specialists to provide support throughout the treatment process.
For physicians, AIC is more than a specialty pharmacy. We are a full-service care delivery partner, and we have contracts with multiple immunoglobulin suppliers, like GC Biopharma. These contracts help us ensure prescribed therapies are always in stock. We also work directly with patients, insurance companies, and physician offices to secure all needed insurance authorizations and approvals.
AIS Healthcare is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers.
Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/
As the leading provider of infusion care solutions and targeted drug delivery, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
GC Biopharma is a global biopharmaceutical company, and a pioneer in the field of specialty pharmaceuticals. It is committed to improving the lives of people around the world and has built a global network of professionals and facilities to make this vision a reality.
GC Biopharma manufactured its first plasma-derived therapy in South Korea in 1971. Since then, the company has grown to become one of the top pharmaceutical manufacturers of plasma therapeutics in the world, distributing to more than 50 countries.
Throughout its history, which spans more than half a century, GC Biopharma has focused heavily on plasma-derived drug products. With one of the largest plasma manufacturing facilities in the world, it is devoted to developing new drugs to achieve its mission and vision.
CONTACT:
Jud Hall
877.443.4006
Stan Singley to serve as Vice President of Trade & Procurement for AIC
Dallas, Texas – AIC, a division of AIS Healthcare, today announced the hiring of Stan Singley as Vice President of Trade and Procurement. In this role, Stan will help drive AIC’s growth and expansion strategy in partnering with pharmaceutical manufacturers to gain limited distribution and sole source access for specialty drugs.
“We are thrilled to welcome a highly respected industry veteran with more than 20+ years of experience in immunology and rare diseases,” said Jud Hall, President at AIC. “Stan will bring a valuable perspective in partnering with internal and external stakeholders as we further develop and execute our trade strategy.”
Recently, Singley served as National Account Manager for Grifols USA, where he was responsible for partnering with key stakeholders to develop and execute channel strategy with key biological distributors, national specialty pharmacies, GPOs and health systems for their plasma-derived & hyperimmune products. Prior to Grifols, Stan was a successful sales professional and manager, culminating in his role as National Accounts Director, over the course of 12 years with Baxter BioScience. In this role, he successfully managed and continued to grow their plasma-derived, recombinant, oncology and biosurgery businesses.
“I’m excited to join the nationally accredited home infusion teams at AIC to further enhance the company’s efforts to advance chronic, rare and specialty therapies requiring complex clinical management,” said Stan Singley, Vice President of Trade & Procurement for AIC. “I truly believe, when the stakes are high for patients, that AIC can rise to the occasion with our comprehensive and differentiated care model and teams.”
Singley holds a Bachelor of Science in Business Administration degree from the University of Alabama.
AIC is dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other infusion services providers. Physicians interested in AIC care services should contact their AIC representatives to get started or visit us at www.aiscaregroup.com/our-divisions/infusion-care/
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com.
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, the leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to announce that it has been named a 2023 Pioneer in URAC’s Leaders in Performance Measurement (LPM) recognition program.
URAC is one of the nation’s leading independent health care accreditation organizations, with certification programs that set the highest standards in quality and safety.
Recently, URAC developed the Leaders in Performance Measurement awards program to highlight the URAC-accredited organizations that are using performance measurement to improve the health and well-being of the populations they serve. Their Pioneer Award recognizes the commitment of AIS Healthcare to promote trust in the quality of care delivered through performance measurement activities.
“We are humbled and honored to have been named a 2023 Pioneer by URAC,” said Simon Castellanos, AIS Healthcare CEO. “This recognition is a testament to the dedication and cohesiveness of our entire company. I could not be prouder of this team and their unwavering commitment to ensuring quality, sterility, and excellence across all our pharmacy operations.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. This accomplishment underscores the company’s commitment to going beyond what’s expected to advance quality care and improve the lives of patients.
AIS Healthcare is also dually accredited by URAC and the Accreditation Commission for Health Care (ACHC), further setting it apart from other compounding pharmacies and infusion services providers.
Learn more at aiscaregroup.com
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com
Founded in 1990, URAC is the independent leader in promoting healthcare quality through leadership, accreditation, measurement and innovation. URAC is a nonprofit organization using evidence-based measures and developing standards through inclusive engagement with a range of stakeholders committed to improving the quality of healthcare. Our portfolio of accreditation and certification programs span the healthcare industry, addressing healthcare management, healthcare operations, health plans, pharmacies, telehealth providers, physician practices and more. URAC accreditation is a symbol of excellence for organizations to showcase their validated commitment to quality and accountability.
Contact:
Simon Castellanos
877.443.4006
Dallas, Texas – AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize May as National Nurses Month. This month and throughout the year, AIS Healthcare celebrates the dedication of nurses who devote themselves to protecting and enhancing the well-being of those in need of care.
Nurses play a critical role in healthcare delivery in the United States and across the world. Thanks to advancements in medical science and technology, their role has expanded, often serving as a first point of contact for patients. AIS Healthcare nurses hold certifications in specialty infusion care and undergo advanced and ongoing clinical training, allowing them to provide patients with the best possible care. AIS Healthcare’s Advanced Nursing Solutions team is led by experienced professionals who understand what it takes to advance quality of life and improve health outcomes for patients afflicted with chronic pain and complex medical conditions.
“National Nurses Month gives us an opportunity to celebrate the pivotal role of nurses and their commitment to improving patient lives,” said Simon Castellanos, CEO of AIS Healthcare. “AIS Healthcare’s nurses deliver comprehensive care services and build strong connections and relationships that enable patients to better thrive in their communities and homes. We are grateful for their selfless dedication today and every day.”
AIS Healthcare’s Advanced Infusion Care (AIC) and TDD divisions utilize innovative healthcare solutions to manage patients’ needs. Collaboration between physicians and the AIS nursing team ensures the efficient delivery of patient-specific services and enhances the care experience for patients managing complex conditions.
Nurses change patient lives for the better. During National Nurses Month and throughout the year, AIS Healthcare encourages individuals, communities, and organizations to show their appreciation for nurses. To learn more about AIS Healthcare’s leading nursing program, visit here.
Advancing quality. Improving lives.
As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.
Learn more at aiscaregroup.com